0001213900-22-019771.txt : 20220414 0001213900-22-019771.hdr.sgml : 20220414 20220414135256 ACCESSION NUMBER: 0001213900-22-019771 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220413 FILED AS OF DATE: 20220414 DATE AS OF CHANGE: 20220414 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Erfanian Hamid CENTRAL INDEX KEY: 0001893172 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 22826775 MAIL ADDRESS: STREET 1: 527 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 4 1 ownership.xml X0306 4 2022-04-13 0 0000316253 ENZO BIOCHEM INC ENZ 0001893172 Erfanian Hamid C/O ENZO BIOCHEM, INC. 527 MADISON AVENUE NEW YORK NY 10022 0 1 0 0 Chief Executive Officer Common Stock, $0.01 Par Value 2022-04-13 4 A 0 10000 2.90 A 270000 D Stock Option (to acquire Common Stock) 3.39 2021-11-08 4 A 0 700000 0 A 2022-11-08 2026-11-08 Common Stock 700000 700000 D The Reporting Person was granted 700,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 8, 2022. /s/ Hamid Erfanian 2022-04-14